ARTICLE | Company News
Oculex other research news
July 8, 1996 7:00 AM UTC
Oculex received a $100,000 Phase I SBIR from the National Eye Institute to develop its intraocular drug delivery systems to treat uveitis (chronic inflammation of the eye). Oculex’s system consists of...